Responsible Clinical Trials Data Sharing
Enable Richer Analysis using De-identification
This webinar examines how organizations can securely and cost-effectively manage their clinical trials by:
- Enhancing risk management practices for clinical trial data release programs to reduce the potential for re-identification of personal information;
- Incorporating re-identification risk measurement and practices to improve the efficiency and auditability of clinical trial data release programs;
- Balancing acceptable levels of risk with utility of de-identified data sets.
Khaled El Emam, CEO and founder of Privacy Analytics, leads the discussion on how pharmaceutical and medical device companies can accelerate, automate and manage privacy risks of their clinical trial data releases.
Dr. El Emam one of only a handful of individual experts in North America qualified to certify the de-identification of Personal Health Information under the HIPAA Privacy Rule.